Enfermería
Saila
![Foto de Emad](/img/nophoto.png)
Emad
Abu Assi
Emad Abu Assi-rekin lankidetzan egindako argitalpenak (17)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
2022
-
Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome
REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211
-
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
European heart journal. Quality of care & clinical outcomes, Vol. 8, Núm. 8, pp. 881-891
2021
-
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
The Lancet, Vol. 397, Núm. 10270, pp. 199-207
-
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182
-
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry
Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416
2020
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
2019
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304
-
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry (American Journal of Cardiovascular Drugs, (2019), 19, 4, (381-391), 10.1007/s40256-019-00339-3)
American Journal of Cardiovascular Drugs
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 6, pp. 536-542
-
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
American Journal of Cardiovascular Drugs, Vol. 19, Núm. 4, pp. 381-391
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Revista Espanola de Cardiologia, Vol. 72, Núm. 3, pp. 215-223
2018
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Thrombosis Research, Vol. 167, pp. 142-148
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
International Journal of Cardiology, Vol. 273, pp. 29-33